+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Neurostimulation Devices Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • March 2021
  • Region: Global
  • TechNavio
  • ID: 5305694
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Neurostimulation Devices Market 2021-2025

The publisher has been monitoring the neurostimulation devices market and it is poised to grow by $ 2.23 bn during 2021-2025, progressing at a CAGR of 8% during the forecast period. The report on neurostimulation devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of neurological disorders and increasing number of awareness initiatives and improvements in access to healthcare. In addition, rising prevalence of neurological disorders is anticipated to boost the growth of the market as well.

The neurostimulation devices market analysis includes product segment and geographical landscapes.

The neurostimulation devices market is segmented as below:

By Product
  • Implantable neurostimulation devices
  • External neurostimulation devices

By Geographical Landscapes
  • North America
  • Europe
  • APAC
  • ROW

This study identifies a rapid increase in aging population as one of the prime reasons driving the neurostimulation devices market growth during the next few years.

The report on neurostimulation devices market covers the following areas:
  • Neurostimulation devices market sizing
  • Neurostimulation devices market forecast
  • Neurostimulation devices market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurostimulation devices market vendors that include Abbott Laboratories, Axonics Modulation Technologies Inc., Bioness Inc., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS INC, NeuroSigma Inc., Nexstim Plc, and Nuvectra Medical. Also, the neurostimulation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Implantable neurostimulation devices - Market size and forecast 2020-2025
  • External neurostimulation devices - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • APAC - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape
  • Competitive scenario
  • Vendor landscape
  • Landscape disruption
  • Industry risks

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Axonics Modulation Technologies Inc.
  • Bioness Inc.
  • LivaNova Plc
  • Medtronic Plc
  • NeuroMetrix Inc.
  • NEURONETICS INC
  • NeuroSigma Inc.
  • Nexstim Plc
  • Nuvectra Medical

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Implantable neurostimulation devices - Market size and forecast 2020-2025 ($ million)
  • Implantable neurostimulation devices - Year-over-year growth 2020-2025 (%)
  • External neurostimulation devices - Market size and forecast 2020-2025 ($ million)
  • External neurostimulation devices - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • APAC - Market size and forecast 2020-2025 ($ million)
  • APAC - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • Axonics Modulation Technologies Inc. - Overview
  • Axonics Modulation Technologies Inc. - Business segments
  • Axonics Modulation Technologies Inc. - Key offerings
  • Axonics Modulation Technologies Inc. - Key customers
  • Axonics Modulation Technologies Inc. - Segment focus
  • Bioness Inc. - Overview
  • Bioness Inc. - Product and service
  • Bioness Inc. - Key offerings
  • Bioness Inc. - Key customers
  • Bioness Inc. - Segment focus
  • LivaNova Plc - Overview
  • LivaNova Plc - Business segments
  • LivaNova Plc - Key offerings
  • LivaNova Plc - Key customers
  • LivaNova Plc - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • NeuroMetrix Inc. - Overview
  • NeuroMetrix Inc. - Business segments
  • NeuroMetrix Inc. - Key offerings
  • NeuroMetrix Inc. - Key customers
  • NeuroMetrix Inc. - Segment focus
  • NEURONETICS INC - Overview
  • NEURONETICS INC - Business segments
  • NEURONETICS INC - Key offerings
  • NEURONETICS INC - Key customers
  • NEURONETICS INC - Segment focus
  • NeuroSigma Inc. - Overview
  • NeuroSigma Inc. - Product and service
  • NeuroSigma Inc. - Key offerings
  • NeuroSigma Inc. - Key customers
  • NeuroSigma Inc. - Segment focus
  • Nexstim Plc - Overview
  • Nexstim Plc - Product and service
  • Nexstim Plc - Key offerings
  • Nexstim Plc - Key customers
  • Nexstim Plc - Segment focus
  • Nuvectra Medical - Overview
  • Nuvectra Medical - Product and service
  • Nuvectra Medical - Key offerings
  • Nuvectra Medical - Key customers
  • Nuvectra Medical - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global neurostimulation devices market: Abbott Laboratories, Axonics Modulation Technologies Inc., Bioness Inc., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS INC, NeuroSigma Inc., Nexstim Plc, and Nuvectra Medical.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is a rapid increase in aging population.'

According to the report, one of the major drivers for this market is the rising prevalence of neurological disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Axonics Modulation Technologies Inc.
  • Bioness Inc.
  • LivaNova Plc
  • Medtronic Plc
  • NeuroMetrix Inc.
  • Neuronetics Inc
  • NeuroSigma Inc.Â
  • Nexstim Plc
  • Nuvectra Medical